Hutmacher MM - Search Results

1

Estimating transformations for repeated measures modeling of continuous bounded outcome data.

Hutmacher MM, French JL, Krishnaswami S, Menon S. Hutmacher MM, et al. Stat Med. 2011 Apr 30;30(9):935-49. doi: 10.1002/sim.4155. Epub 2011 Jan 13. Stat Med. 2011. PMID: 21472758

2

Extending the latent variable model for extra correlated longitudinal dichotomous responses.

Hutmacher MM, French JL. Hutmacher MM, et al. J Pharmacokinet Pharmacodyn. 2011 Dec;38(6):833-59. doi: 10.1007/s10928-011-9222-4. Epub 2011 Oct 22. J Pharmacokinet Pharmacodyn. 2011. PMID: 22038327

3

Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients.

Hutmacher MM, Krishnaswami S, Kowalski KG. Hutmacher MM, et al. J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):139-57. doi: 10.1007/s10928-007-9080-2. Epub 2007 Dec 6. J Pharmacokinet Pharmacodyn. 2008. PMID: 18058203

4

Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.

Lamba M, Hutmacher MM, Furst DE, Dikranian A, Dowty ME, Conrado D, Stock T, Nduaka C, Cook J, Krishnaswami S. Lamba M, et al. Among authors: hutmacher mm. Clin Pharmacol Ther. 2017 Jun;101(6):745-753. doi: 10.1002/cpt.576. Epub 2017 Feb 9. Clin Pharmacol Ther. 2017. PMID: 27859030 Free PMC article.

5

Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight.

Hutmacher MM, Papp K, Krishnaswami S, Ito K, Tan H, Wolk R, Valdez H, Mebus C, Rottinghaus ST, Gupta P. Hutmacher MM, et al. CPT Pharmacometrics Syst Pharmacol. 2017 May;6(5):322-330. doi: 10.1002/psp4.12182. Epub 2017 Mar 20. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28317328 Free PMC article. Clinical Trial.

6

Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials.

Isaacs JD, Zuckerman A, Krishnaswami S, Nduaka C, Lan S, Hutmacher MM, Boy MG, Kowalski K, Menon S, Riese R. Isaacs JD, et al. Among authors: hutmacher mm. Arthritis Res Ther. 2014 Jul 25;16(4):R158. doi: 10.1186/ar4673. Arthritis Res Ther. 2014. PMID: 25063045 Free PMC article. Clinical Trial.

7

Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritis.

Krishnaswami S, Hutmacher MM, Robbins JL, Bello A, West C, Bloom BJ. Krishnaswami S, et al. Among authors: hutmacher mm. J Clin Pharmacol. 2012 Aug;52(8):1134-49. doi: 10.1177/0091270011412184. Epub 2011 Aug 30. J Clin Pharmacol. 2012. PMID: 21878579 Clinical Trial.

8

Evaluation of estimation, prediction and inference for autocorrelated latent variable modeling of binary data-a simulation study.

Hutmacher MM. Hutmacher MM. J Pharmacokinet Pharmacodyn. 2016 Jun;43(3):275-89. doi: 10.1007/s10928-016-9471-3. Epub 2016 Mar 23. J Pharmacokinet Pharmacodyn. 2016. PMID: 27007275

9

Use of statistical and pharmacokinetic-pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conference.

Kimko H, Berry S, O'Kelly M, Mehrotra N, Hutmacher M, Sethuraman V. Kimko H, et al. J Biopharm Stat. 2017;27(3):554-567. doi: 10.1080/10543406.2017.1289956. Epub 2017 Feb 7. J Biopharm Stat. 2017. PMID: 28304215

10

Collapsing mechanistic models: an application to dose selection for proof of concept of a selective irreversible antagonist.

Hutmacher MM, Mukherjee D, Kowalski KG, Jordan DC. Hutmacher MM, et al. J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):501-20. doi: 10.1007/s10928-005-0052-0. J Pharmacokinet Pharmacodyn. 2005. PMID: 16320102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters